Company Number: 15111995

Analysis Date: 2025-07-29 20:23 UTC

Financial Health Assessment for NOSTEOPATHY LIMITED

---

1. Financial Health Score: Grade A

Explanation:
NOSTEOPATHY LIMITED is currently classified as a dormant company with minimal financial activity and negligible financial transactions. The company has a clean, straightforward balance sheet with net assets and cash of £1, reflecting its dormant status. There are no signs of financial distress or operational activity, which is expected for a dormant entity. Given these facts, the company demonstrates a stable baseline financial condition with no adverse symptoms.

---

2. Key Vital Signs

Metric	Value	Interpretation
Company Status	Active	The company is legally active and compliant.
Account Category	Dormant	No significant financial transactions during the year.
Cash at Bank	£1	Minimal cash, typical for a dormant company.
Net Assets	£1	Equity equals share capital; no liabilities or other assets recorded.
Shareholders’ Funds	£1	Reflects the initial share capital only.
Filing Compliance	Up to date	Accounts and confirmation statements are filed on time, indicating good governance.
Director/PSC	Single Director with full control	Control concentrated in one individual, typical for small private companies.

---

3. Diagnosis

NOSTEOPATHY LIMITED currently shows all the classic "vital signs" of a dormant company—a business entity that has been registered but not yet operational or generating revenue. The "healthy cash flow" is essentially neutral, as there are no active receipts or payments. The balance sheet is minimal, with the only asset being the nominal share capital, indicating the company has not engaged in trading or incurred liabilities.

There are no symptoms of financial distress such as overdue filings, liabilities, negative net assets, or cash flow issues. The presence of a single director who is also the sole person of significant control suggests a tightly managed ownership structure, which is common for start-ups or newly incorporated companies awaiting operational commencement.

However, the company’s financial "heartbeat" is currently dormant—it has not started business activities or generated financial results for assessment. This is typical for a new company formed in 2023, and it may be in a preparatory or planning stage.

---

4. Recommendations

• Activate Financial Monitoring Upon Trading: Once the company begins trading or incurs financial transactions, implement regular financial monitoring to track cash flow, profitability, and working capital to avoid early-stage distress.

• Maintain Compliance: Continue timely filing of accounts and confirmation statements to maintain a clean compliance record, which supports financial and reputational health.

• Prepare for Operational Expenses: Before trading starts, ensure adequate capital funding or access to working capital to avoid cash flow "symptoms" such as insufficient liquidity.

• Consider Business Planning: Use this dormant phase to develop detailed financial projections and budgets, which will serve as diagnostic tools once active trading begins.

• Review Governance: While current governance is simple, consider appointing a company secretary or additional directors as the company grows to strengthen oversight.

---